Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure of Cadherins01:25

Structure of Cadherins

5.2K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
5.2K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

2.0K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
2.0K
Complement System01:27

Complement System

12.3K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
12.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.2K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

7.1K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.1K
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

4.5K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Exploring Neurological Disorder Therapeutics: The Progress and Future Prospects of Proteins and Peptides Derived from Blue Foods.

Current protein & peptide science·2026
Same journal

Significance of Proteomics in Cancer: Current Approaches and Trends in Biomarker Discovery.

Current protein & peptide science·2026
Same journal

Therapeutic Peptides as Targeting Vectors and Smart Therapeutics: Emerging Trends and Future Perspectives.

Current protein & peptide science·2026
Same journal

Innovative Protein Nanostructures and Hybrid Systems for Enhanced Encapsulation and Controlled Delivery of Bioactive Agents.

Current protein & peptide science·2026
Same journal

Nanotherapeutic Interventions in Diabetic Wound Healing: Biomarker- Guided Mechanisms and Translational Prospects.

Current protein & peptide science·2026
Same journal

Recent developments in intein-mediated protein splicing and their applications in bioengineering.

Current protein & peptide science·2026

Related Experiment Video

Updated: Mar 25, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.3K

The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).

Jonathan Paul Hannan1

  • 1Division of Rheumatology, Mail Stop B-115, Department of Medicine, Barbara Davis Center for Childhood Diabetes, Anschutz Medical Campus, University of Colorado Denver, 1775 Aurora Court, Aurora CO 80045, USA. Jonathan.Hannan@ucdenver.edu.

Current Protein & Peptide Science
|February 27, 2016
PubMed
Summary

Human complement receptor type 2 (CR2; CD21) binds C3d, CD23, and EBV proteins, linking innate and adaptive immunity. Understanding CR2 interactions is key for developing therapies for autoimmune and inflammatory diseases.

More Related Videos

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

7.8K
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on: July 5, 2018

13.3K

Related Experiment Videos

Last Updated: Mar 25, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.3K
Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

7.8K
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on: July 5, 2018

13.3K

Area of Science:

  • Immunology
  • Molecular Biology
  • Structural Biology

Background:

  • Human complement receptor type 2 (CR2; CD21) is a cell surface glycoprotein.
  • CR2 binds complement fragments (iC3b, C3dg, C3d), CD23, and interferon-alpha.
  • CR2 bridges innate and adaptive immunity by linking complement-tagged targets to B cell activation.

Purpose of the Study:

  • To review CR2 interactions with its key ligands: C3d, CD23, and EBV gp350/220.
  • To highlight the current understanding of CR2-ligand complex structures.
  • To underscore the importance of structure-function relationships for therapeutic applications.

Main Methods:

  • Literature review of CR2 interactions.
  • Analysis of structural data for CR2-ligand complexes.
  • Discussion of physiological and disease-associated implications.

Main Results:

  • CR2 binds C3d, CD23, and EBV gp350/220.
  • Only the CR2-C3d complex structure is fully elucidated.
  • Interactions with CD23 and EBV gp350/220 are incompletely understood but physiologically and disease-relevant.

Conclusions:

  • Detailed knowledge of CR2 structure-function relationships is crucial.
  • Understanding these interactions can inform the development of recombinant CR2 therapeutics or targeted CR2 therapies for autoimmunity.